Saturday, September 29, 2018

Insmed's treatment-resistant lung disease drug gets FDA approval (Reuters) - The U.S. Food and Drug Administration on Friday approved Insmed Inc's lead drug to treat a rare, chronic lung disease, making it the first ... https://t.co/YYQzKViyfY


Source: @methadoneUSA September 29, 2018 at 03:58PM
More info Methadone Clinics USA

No comments:

Post a Comment